Our Story
The Architecture of Antibody Precision
Founded in 2018, Afinite emerged from a simple observation: clinical research requires more than just molecules; it needs technical precision. We architect engineered antibodies that bridge the critical gap between theoretical research and laboratory execution, ensuring every synthesis meets the absolute standards of reproducibility.
The Scientific Pursuit of Excellence
Our Mission
Empowering Global Research
To provide laboratory-grade engineered antibodies with surgical precision, enabling scientific breakthroughs through absolute reproducibility and technical mastery.
Our Vision
Architecting the Future of Biotech
To become the definitive technical architecture for biological research, where every synthesis is a benchmark for quality and innovation in the global scientific landscape.
The Scientific Leadership
Architects of Precision Immunology
Dr. Julian Voss
Chief Scientific Officer, PhD Immunology
Dr. Elena Moretti
Head of Antibody Engineering, PhD Pharmacology
Dr. Marcus Thorne
Lead Synthetic Architect, PhD Molecular Biology
[01]
Protocol Validation
Continuous assessment of antibody specificity using multi-stage mass spectrometry and high-resolution imaging to verify molecular composition.
Our Scientific Standards
We adhere to rigorous protocols and globally recognized quality benchmarks, ensuring that every synthesized molecule delivers absolute reproducibility in clinical environments.
[02]
Batch Reproducibility
Strict adherence to technical precision ensures that synthesis from one batch to the next remains functionally identical for clinical researchers.
[03]
Analytical Integrity
Full transparency in data synthesis, providing research laboratories with the architecture and raw analytics needed for global publication standards.